The role of cytokine mRNA stability in the pathogenesis of autoimmune disease

Autoimmunity Reviews

Volumn 5, Issue 5, 2006, Pages 299-305

  Seko, Yuko ^a   Cole, Steven ^a   Kasprzak, Wojciech ^b   Shapiro, Bruce A ^b   Ragheb, Jack A ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autoimmune disease; HuR; IFN ; IL 2; mRNA; TNF ; TTP

Indexed keywords

CD28 ANTIGEN; CIS ACTING ELEMENT; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HUR PROTEIN; INTERLEUKIN 17; INTERLEUKIN 2; MESSENGER RNA; NEUTRALIZING ANTIBODY; NUCLEOLIN; RNA BINDING PROTEIN; TRANS ACTING FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; Y BOX BINDING PROTEIN 1;

3' UNTRANSLATED REGION; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CLINICAL TRIAL; DNA POLYMORPHISM; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HALF LIFE TIME; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; REVIEW; RNA ANALYSIS; RNA STABILITY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; INTERLEUKIN-2; MICE; RNA STABILITY;

EID: 33744966820     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2005.10.013     Document Type: Review

References (40)

1. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16 1 (1995) 34-38
2. Khoury S.J., Hancock W.W., and Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176 5 (1992) 1355-1364
3. Kennedy M.K., Torrance D.S., Picha K.S., and Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149 7 (1992) 2496-2505
4. De Vos A.F., Hoekzema R., and Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res 11 6 (1992) 581-597
5. 1 response. J Immunol 157 6 (1996) 2668-2675
6. 1-dependent autoimmune disease. Eur J Immunol 23 12 (1993) 3096-3103
7. Hooks J.J., Chan C.C., and Detrick B. Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. Invest Ophthalmol Vis Sci 29 9 (1988) 1444-1451
8. McDyer J.F., Li Z., John S., Yu X., Wu C.Y., and Ragheb J.A. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and-independent pathways of IFN-gamma production. J Immunol 169 5 (2002) 2736-2746
9. Nussenblatt R.B., Fortin E., Schiffman R., et al. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proc Natl Acad Sci U S A 96 13 (1999) 7462-7466
10. Ross J. mRNA stability in mammalian cells. Microbiol Rev 59 3 (1995) 423-450
11. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., and Cerami A. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A 83 6 (1986) 1670-1674
12. Shaw G., and Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46 5 (1986) 659-667
13. Raghavan A., Ogilvie R.L., Reilly C., et al. Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes. Nucleic Acids Res 30 24 (2002) 5529-5538
14. Loflin P., Chen C.Y., and Shyu A.B. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev 13 14 (1999) 1884-1897
15. Zhang W., Wagner B.J., Ehrenman K., et al. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol Cell Biol 13 12 (1993) 7652-7665
16. Laroia G., Cuesta R., Brewer G., and Schneider R.J. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science 284 5413 (1999) 499-502
17. Chen C.Y., Gherzi R., Ong S.E., et al. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107 4 (2001) 451-464
18. Peng S.S., Chen C.Y., Xu N., and Shyu A.B. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17 12 (1998) 3461-3470
19. Fan X.C., and Steitz J.A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17 12 (1998) 3448-3460
20. Seko Y., Azmi H., Fariss R., and Ragheb J.A. Selective cytoplasmic translocation of HuR and site-specific binding to the interleukin-2 mRNA are not sufficient for CD28-mediated stabilization of the mRNA. J Biol Chem 279 32 (2004) 33359-33367
21. 2-terminal kinase pathway. Science 280 5371 (1998) 1945-1949
22. Ragheb J.A., Deen M., and Schwartz R.H. CD28-mediated regulation of mRNA stability requires sequences within the coding region of the IL-2 mRNA. J Immunol 163 1 (1999) 120-129
23. Lindstein T., June C.H., Ledbetter J.A., Stella G., and Thompson C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244 4902 (1989) 339-343
24. Henics T., Sanfridson A., Hamilton B.J., Nagy E., and Rigby W.F. Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins. J Biol Chem 269 7 (1994) 5377-5383
25. Ogilvie R.L., Abelson M., Hau H.H., Vlasova I., Blackshear P.J., and Bohjanen P.R. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J Immunol 174 2 (2005) 953-961
26. Meisner N.C., Hackermuller J., Uhl V., Aszodi A., Jaritz M., and Auer M. mRNA openers and closers: modulating AU-rich element-controlled mRNA stability by a molecular switch in mRNA secondary structure. Chembiochem 5 10 (2004) 1432-1447
27. Shapiro B.A., Bengali D., Kasprzak W., and Wu J.C. RNA folding pathway functional intermediates: their prediction and analysis. J Mol Biol 312 1 (2001) 27-44
28. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 43 3 (1995) 227-235
29. Shalaby M.R., Fendly B., Sheehan K.C., Schreiber R.D., and Ammann A.J. Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha. Transplantation 47 6 (1989) 1057-1061
30. Keffer J., Probert L., Cazlaris H., et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10 13 (1991) 4025-4031
31. Reimund J.M., Wittersheim C., Dumont S., et al. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 16 3 (1996) 144-150
32. Abraham E., Glauser M.P., Butler T., et al. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277 19 (1997) 1531-1538
33. Lorenz H.M., Antoni C., Valerius T., et al. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol 156 4 (1996) 1646-1653
34. Kontoyiannis D., Pasparakis M., Pizarro T.T., Cominelli F., and Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10 3 (1999) 387-398
35. Carballo E., Lai W.S., and Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281 5379 (1998) 1001-1005
36. Taylor G.A., Carballo E., Lee D.M., et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4 5 (1996) 445-454
37. Linker-Israeli M., Wallace D.J., Prehn J., et al. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun 1 1 (1999) 45-52
38. Kantarci O.H., Goris A., Hebrink D.D., et al. IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis. Genes Immun 6 2 (2005) 153-161
39. Chowdhury B., Tsokos C.G., Krishnan S., et al. Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3′-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus. J Biol Chem 280 19 (2005) 18959-18966
40. Tsuzakam K., Setoyama Y., Yoshimoto K., et al. A splice variant of the TCR zeta mRNA lacking exon 7 leads to the down-regulation of TCR zeta, the TCR/CD3 complex, and IL-2 production in systemic lupus erythematosus T cells. J Immunol 174 6 (2005) 3518-3525